Sunzen Group Berhad (KLSE:SUNZEN)

Market Cap	223.35M
Revenue (ttm)	95.12M
Net Income (ttm)	6.03M
Shares Out	812.18M
EPS (ttm)	0.01
PE Ratio	37.50
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	87,600
Average Volume	705,035
Open	0.2700
Previous Close	0.2750
Day's Range	0.2700 - 0.2750
52-Week Range	0.2600 - 0.3550
Beta	0.67
RSI	48.80
Earnings Date	Aug 26, 2025

About Sunzen Group Berhad

Sunzen Group Berhad engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through three segments: Animal Health, Human Health, and Loan Financing. The company provides veterinary machines, pharmaceutical, chemical products, animal health products and equipment, laboratory services, and beauty and cosmetic products. It also manufactures and sells traditional Chinese medicine, herbal health foods, beverages, and other p...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Country: Malaysia
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: SUNZEN

Financial Performance

In 2024, Sunzen Group Berhad's revenue was 95.12 million, a decrease of -3.07% compared to the previous year's 98.13 million. Earnings were 6.03 million, a decrease of -11.35%.